image 2 image 4
Skip Navigation Links
 Home 
 Congress Structure 
 Important Dates 
 Venue 
 Registration 
 Pre Registered 
 Abstracts 
 Scientific Program 
 Photo and Film Festival 
 Exhibition 
 Contact Us 
 Personal page 
 past Guest Speakers 
       XXIX Annual Congress of the Iranian Society of Ophthalmology        بـیــست و نهمین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران
مقاله Abstract


Title: Safety and efficacy of the new implantable phakic contact lens for the correction of myopia
Author(s): Khosrow Jadidi, Farhad Nejat, Shiva Pirhadi,Hossein Aghamollaei
Presentation Type: Oral
Subject: Cornea and Anterior Segment
Others:
Presenting Author:
Name: Khosrow Jadidi
Affiliation :(optional) Vision Health Research Center, Semnan University of Medical Sciences, Semnan, Iran
E mail: kh.jadidi@gmail.com
Phone:
Mobile: 09121053475
Purpose:

: To evaluation of the safety and efficacy of the implantable phakic contact lens (IPCL V1, Care group Sight Solutions, India) for correction of myopia and myopic astigmatism.

Methods:

This study including 28 eyes which underwent IPCL implantation for correction of myopia and myopic astigmatism. Visual acuity and manifest refraction, slit lamp bio microscopy, IOP and endothelial cell density was analysed postoperatively and compared with preoperative visits. Also Intraoperative and postoperative complications were evaluated.

Results:

The mean age of patient was 39.9 ±8.25 years old. the mean follow up was 5.1 months. Preoperative BCVA, sphere and astigmatism was 0.65 ± 0.18, -6.4 ±3.1 and -3.7±2.9 respectively. This parameters reach to 0.94±0.07, -0.2 ±0.3 and -0.88 ± 0.62 postoperatively. There are significant differences between this parameters at pre and post visits. (P< 0.05). At the preoperative visits, patients showed count fingers vision about 2 meters. The mean post operative UCVA reach to 0.71D ( range 0.4 to 1). No intraoperative complications were noted. The endothelial cell loss was 4.08%±3.18%. lens rotation was seen in one patient .One eye developed iris capture lens. No vision threatening complications were noted.

Conclusion:

The IPCL is a safe and effective treatment modality for correction of myopia and myopic astigmatism.

Attachment:





Skip Navigation Links
        صفحه اصلی
        ساختار کنگره
        تاریخ های مهم
        مکان برگزاری
        ثبت نام
        ثبت نام شدگان
        اطلاعات رزرو هتل
        مقالات
        برنامه کنگره
        جشنواره فیلم و عکس
        نمایشگاه
        تماس با ما
        صفحه شخصی
        جستجوی سخنران
        تور مجازی مجتمع سپید مشهد
        آرشیو کنگره سالهای گذشته
        آرشیو سخنرانان مهمان
 
ورود شرکت کنندگان
نام کاربری :
کلمه عبور :
  کلمه عبور خود را فراموش کرده ام.
Total Visits


Congress Count Down
Today Label
Last Month Label
Total Visitors Label